Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

MicroRNA-302a sensitizes testicular embryonal carcinoma cells to cisplatin-induced cell death.

Liu L, Lian J, Zhang H, Tian H, Liang M, Yin M, Sun F.

J Cell Physiol. 2013 Dec;228(12):2294-304. doi: 10.1002/jcp.24394.

PMID:
23625774
2.

Therapeutic potential of Mdm2 inhibition in malignant germ cell tumours.

Bauer S, Mühlenberg T, Leahy M, Hoiczyk M, Gauler T, Schuler M, Looijenga L.

Eur Urol. 2010 Apr;57(4):679-87. doi: 10.1016/j.eururo.2009.06.014. Epub 2009 Jun 21.

PMID:
19560254
3.

Downregulation of microRNA-383 is associated with male infertility and promotes testicular embryonal carcinoma cell proliferation by targeting IRF1.

Lian J, Tian H, Liu L, Zhang XS, Li WQ, Deng YM, Yao GD, Yin MM, Sun F.

Cell Death Dis. 2010 Nov 4;1:e94. doi: 10.1038/cddis.2010.70.

5.

Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells.

Card DA, Hebbar PB, Li L, Trotter KW, Komatsu Y, Mishina Y, Archer TK.

Mol Cell Biol. 2008 Oct;28(20):6426-38. doi: 10.1128/MCB.00359-08. Epub 2008 Aug 18.

6.

Role of SOX2 in the etiology of embryonal carcinoma, based on analysis of the NCCIT and NT2 cell lines.

Eini R, Stoop H, Gillis AJ, Biermann K, Dorssers LC, Looijenga LH.

PLoS One. 2014 Jan 3;9(1):e83585. doi: 10.1371/journal.pone.0083585. eCollection 2014.

7.

Hsa-miR-513b-5p suppresses cell proliferation and promotes P53 expression by targeting IRF2 in testicular embryonal carcinoma cells.

Wang X, Zhang X, Wang G, Wang L, Lin Y, Sun F.

Gene. 2017 Aug 30;626:344-353. doi: 10.1016/j.gene.2017.05.033. Epub 2017 May 13.

PMID:
28512062
8.
9.

Serine/threonine kinase 17A is a novel p53 target gene and modulator of cisplatin toxicity and reactive oxygen species in testicular cancer cells.

Mao P, Hever MP, Niemaszyk LM, Haghkerdar JM, Yanco EG, Desai D, Beyrouthy MJ, Kerley-Hamilton JS, Freemantle SJ, Spinella MJ.

J Biol Chem. 2011 Jun 3;286(22):19381-91. doi: 10.1074/jbc.M111.218040. Epub 2011 Apr 13.

10.

Acute hypersensitivity of pluripotent testicular cancer-derived embryonal carcinoma to low-dose 5-aza deoxycytidine is associated with global DNA Damage-associated p53 activation, anti-pluripotency and DNA demethylation.

Biswal BK, Beyrouthy MJ, Hever-Jardine MP, Armstrong D, Tomlinson CR, Christensen BC, Marsit CJ, Spinella MJ.

PLoS One. 2012;7(12):e53003. doi: 10.1371/journal.pone.0053003. Epub 2012 Dec 27.

11.

Syndecan-1 responsive microRNA-126 and 149 regulate cell proliferation in prostate cancer.

Fujii T, Shimada K, Tatsumi Y, Fujimoto K, Konishi N.

Biochem Biophys Res Commun. 2015 Jan 2;456(1):183-9. doi: 10.1016/j.bbrc.2014.11.056. Epub 2014 Nov 22.

PMID:
25462564
12.

Retinoic acid activates p53 in human embryonal carcinoma through retinoid receptor-dependent stimulation of p53 transactivation function.

Curtin JC, Dragnev KH, Sekula D, Christie AJ, Dmitrovsky E, Spinella MJ.

Oncogene. 2001 May 3;20(20):2559-69.

13.

miR-34 miRNAs provide a barrier for somatic cell reprogramming.

Choi YJ, Lin CP, Ho JJ, He X, Okada N, Bu P, Zhong Y, Kim SY, Bennett MJ, Chen C, Ozturk A, Hicks GG, Hannon GJ, He L.

Nat Cell Biol. 2011 Oct 23;13(11):1353-60. doi: 10.1038/ncb2366.

14.

microRNA-199a-3p, DNMT3A, and aberrant DNA methylation in testicular cancer.

Chen BF, Gu S, Suen YK, Li L, Chan WY.

Epigenetics. 2014 Jan;9(1):119-28. doi: 10.4161/epi.25799. Epub 2013 Aug 19.

15.

Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines.

Burger H, Nooter K, Boersma AW, Kortland CJ, Stoter G.

Br J Cancer. 1998 May;77(10):1562-7.

16.

Loss of Oct-3/4 expression in embryonal carcinoma cells is associated with induction of cisplatin resistance.

Mueller T, Mueller LP, Luetzkendorf J, Voigt W, Simon H, Schmoll HJ.

Tumour Biol. 2006;27(2):71-83. Epub 2006 Mar 24.

PMID:
16557044
17.

Cisplatin hypersensitivity of testicular germ cell tumors is determined by high constitutive Noxa levels mediated by Oct-4.

Gutekunst M, Mueller T, Weilbacher A, Dengler MA, Bedke J, Kruck S, Oren M, Aulitzky WE, van der Kuip H.

Cancer Res. 2013 Mar 1;73(5):1460-9. doi: 10.1158/0008-5472.CAN-12-2876. Epub 2013 Jan 9.

18.

miR-181a and miR-630 regulate cisplatin-induced cancer cell death.

Galluzzi L, Morselli E, Vitale I, Kepp O, Senovilla L, Criollo A, Servant N, Paccard C, Hupé P, Robert T, Ripoche H, Lazar V, Harel-Bellan A, Dessen P, Barillot E, Kroemer G.

Cancer Res. 2010 Mar 1;70(5):1793-803. doi: 10.1158/0008-5472.CAN-09-3112. Epub 2010 Feb 9.

19.

Pro- and anti-apoptotic effects of p53 in cisplatin-treated human testicular cancer are cell context-dependent.

di Pietro A, Koster R, Boersma-van Eck W, Dam WA, Mulder NH, Gietema JA, de Vries EG, de Jong S.

Cell Cycle. 2012 Dec 15;11(24):4552-62. doi: 10.4161/cc.22803. Epub 2012 Nov 19.

20.

Low p21Waf1/Cip1 protein level sensitizes testicular germ cell tumor cells to Fas-mediated apoptosis.

Spierings DC, de Vries EG, Stel AJ, te Rietstap N, Vellenga E, de Jong S.

Oncogene. 2004 Jun 17;23(28):4862-72.

PMID:
15122333

Supplemental Content

Support Center